| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 05, 2024 | Sale | $9.73 | 9,200 | 89,533 | 6,209 | Feb 07, 2024, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2024 | Sale | $10.59 | 9,200 | 97,400 | 6,209 | Jan 08, 2024, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2023 | Option Exercise | $9.16 | 9,200 | 84,280 | 6,209 | Dec 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 22, 2023 | Option Exercise | $8.51 | 27,600 | 234,852 | 15,409 | Nov 27, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05, 2023 | Sale | $9.66 | 4,500 | 43,470 | 3,859 | Jul 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Option Exercise | $9.14 | 4,500 | 41,131 | 3,859 | Jun 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Sale | $11.45 | 4,500 | 51,512 | 3,859 | May 09, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Option Exercise | $10.11 | 4,500 | 45,497 | 3,859 | Apr 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Sale | $12.89 | 4,500 | 57,995 | 3,859 | Mar 08, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Option Exercise | $13.15 | 4,500 | 59,167 | 3,859 | Feb 08, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Sale | $14.21 | 4,500 | 63,960 | 3,859 | Jan 09, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Option Exercise | $9.70 | 4,500 | 43,669 | 3,859 | Dec 07, 2022, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Sale | $10.61 | 4,500 | 47,749 | 3,859 | Nov 09, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Sale | $8.89 | 4,500 | 40,002 | 3,859 | Oct 07, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Option Exercise | $10.51 | 4,500 | 47,305 | 3,859 | Sep 07, 2022, 05:30 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Sale | $11.60 | 4,500 | 52,212 | 3,859 | Aug 19, 2022, 05:00 PM |
Menu